Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Total Voting Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 1 December 2023 Redde Northgate plc - Total Voting Rights   The following notification is made in accordance with Rule 5.6 of the FCA's Disclosure Guidance and Transparency Rules. As at 1 December 2023, Redde Northgate PLC confirms that its share capital consists of 246,091,423 ordinary shares of 50p each, of which 16,865,071 ordinary shares are held

Martin Sonntag appointed as new Chief Executive Officer to Oterra

Oterra, the world’s leading supplier of natural colors, today announces the appointment of Martin Sonntag as its new CEO as of 1 January 2024.Currently a member of the Doehler executive leadership team, Martin has been instrumental in achieving significant growth of the Doehler business and strengthening the company’s position in the food and beverage ingredients market. Previously Martin, inter alia, was with the Dow Chemical Company where he held technical, manufacturing, and commercial roles of increasing responsibility in a highly international setting. Prior to joining Doehler

Bengt Nilsson appointed Chairman of GENA

On 30 November 2023, Pagero’s CEO Bengt Nilsson was appointed Chairman of GENA (Global Exchange Network Association) at its annual general assembly meeting.GENA, formerly EESPA (European E-invoicing Service Providers Association), is a trade association and community for 100+  service providers from various sectors that was established in 2011. “I am thankful for the continued trust from the community and look forward to continuing to shape this industry together with our GENA members around the world. I believe that ‘openness’ is the future of e-document exchange and effective and

Vattenfall and SSAB in new fossil-free steel collaboration

Vattenfall and SSAB have signed a letter of intent regarding deliveries of fossil-free steel produced with HYBRIT technology. SSAB will, using input material from the HYBRIT pilot plant in Lulea, deliver fossil-free steel to Vattenfall, to use in its own operations.In addition to the already existing HYBRIT initiative from 2016, Vattenfall and SSAB are starting another in-depth collaboration to transform the steel industry towards fossil-free steelmaking, promote the use of fossil-free steel and manufacture products with a radically reduced carbon footprint. Vattenfall needs high-

SSAB and Vattenfall in new fossil-free steel collaboration

SSAB and Vattenfall have signed a letter of intent regarding deliveries of fossil-free steel produced with HYBRIT technology. SSAB will, using input material from the HYBRIT pilot plant in Luleå, deliver fossil-free steel to Vattenfall to use in its operations. Photo from left: Annika Ramsköld at Vattenfall and Christina Friborg at SSAB. In addition to the already existing HYBRIT initiative from 2016, Vattenfall and SSAB are starting another in-depth collaboration to transform the steel industry towards fossil-free steelmaking, promote the use of fossil-free steel and manufacture

Vestas wins 46 MW order in Japan

News release from Vestas Asia PacificSeoul, 1 December 2023 Vestas has secured a 46 MW repowering order with Eurus Energy Holdings Corporation for Eurus Kamaishi Wind Farm in Iwate prefecture, Japan. The order includes supply and supervision of installation of 11 units of V117-4.2 MW wind turbines. Vestas will also deliver a multi-year Active Output Management 4000 (AOM 4000) service for the wind farm, providing an energy-based availability guarantee to ensure optimised performance and long-term business case certainty for the customer. “We are pleased to partner with Eurus

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 211 - 1 DECEMBER 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

MapsPeople A/S announces completion of private placement

MapsPeople A/SCompany Announcement No. 33-2023Aalborg, December 1, 2023Completion of Private Placement  With reference to company announcements no. 30-2023 and 32-2023, MapsPeople A/S ("MapsPeople") hereby announces that the private placement of new shares ("New Shares") directed to current shareholders (the "Private Placement") resulting in gross proceeds of approximately DKK 8,510,619.75 is successfully completed.  Registration of 7,151,781 New Shares of a nominal value of DKK 0.02 each, corresponding to a share capital increase of nominal amount of DKK 143,035.62 has today

TORM plc capital increase in connection with delivery of one 2016-built MR vessel

With reference to Company Announcement no. 23 dated 09 November 2023 regarding TORM plc Q3 2023 results where TORM announced the acquisition of four 2015-2016 built MR product tanker vessels, TORM plc (“TORM”) has increased its share capital by 696,429 A-shares (corresponding to USD 6,964.29) as a result of the delivery of the first of the four aforementioned vessels.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. The new shares relate to the settlement of a USD 19.5m allocated loan note issued in connection with each vessel

Epical divests its SAP consulting business to Pearl Finland Oy

Nordic data consultancy Epical has signed an agreement according to which Epical Finland Oy divests its SAP consulting business to Pearl Finland Oy. Epical is the former consulting business division within Enfo. The divestment supports Epical’s strategic approach to be a leading pure-play data consultancy in the Nordics.The divestment of the SAP business is a continuation of Epical’s strategy to sharpen the positioning to accelerate growth. It will also improve the competitiveness of Epical as the business can focus on its mission to be a leading data consultancy in the Nordics, specialized

Isofol is liquidating a subsidiary

GOTHENBURG, Sweden, December 1, 2023 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the subsidiary Isofol Medical (Incentive) AB, which has been dormant since 2021, will be liquidated.The information in the press release is intended for investors. The purpose of the wholly owned subsidiary Isofol Medical (Incentive) AB was to handle warrants for employees. The subsidiary has been dormant since December 2021 when the last warrants were handed over to the employees. The subsidiary's liquidation will lead to reduced costs for Isofol Medcial AB (publ). Any

Queen Silvia Nursing Award 2023 announcement dates revealed

The Queen Silvia Nursing Award (QSNA) will announce the 2023 winners between December 18 - 22. These dates coincide with Her Majesty The Queen of Sweden's birthday on the 23 December.The Queen Silvia Nursing Award (QSNA) is an annual award that promotes innovation and improve practices in elderly and dementia care. Since the first prize was awarded in 2013, the award has encouraged nurses, healthcare assistants and students in these two disciplines to contribute ideas that improve care for older people and people living with cognitive impairment. The award serves as a platform for care

WPTG maintains strong profitable growth in H2 2023

White Pearl Technologies Group (WPTG) positive performance from the first half of 2023 continues into the second half. Group CEO Marco Marangoni highlights increase in margins attributed to cost efficiency and organic growth outcomes. This means that the company group expect the margins to remain within the targeted 12 to14 percent range in the total year of 2023.H1 2023 witnessed 48 percent revenue growth over H2 2022 figures, exceeding SEK 116 million overall. This substantial organic expansion outcome exceeded targets and further validated the strength of WPTG’s business model. 2023

Calliditas announces additions to the management team

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the company has added a new member to its management team, Head of Technical Operations Lars Stubberud. Additionally, the company is welcoming Brian Gorman as its new Group General Counsel. These changes will take effect on 1 January 2024.Brian Gorman is an accomplished legal and business executive with more than 20 years of experience advising corporate boards and executive management teams of life science companies. He joins Calliditas after having served most recently as Executive Vice

Ivar Vatne appointed CEO of Billerud

The Board of Billerud has appointed Ivar Vatne to be the President and CEO of Billerud. Ivar Vatne has been acting President and CEO since July 2023 and enters the permanent position with immediate effect.“The Board has conducted a thorough recruitment process and has evaluated both internal and external candidates. We are very pleased that Ivar is willing to take on the job and it shows real strength that we find the best candidate within the company. Ivar is a highly appreciated leader, and he has deep knowledge about the company’s strategic direction. He has also proved that he

#23-107 Trading halt in BellPal Holding AB

NGM has decided to halt the trading in the shares of BellPal Holding AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The trade halt is due to non-disclosure of inside information about the issuer or the issuer’s financial instruments pursuant Chapter 22, Section 1, Paragraph 3 of the Securities Market Act. The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities

ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development

Hørsholm, Denmark, 1 December 2023 – ExpreS[2]ion Biotech Holding AB’s affiliate ExpreS[2]ion Biotechnologies ApS (“ExpreS2ion") today announces the award of a Horizon Europe grant amounting to 8 million EUR, approximately 90 million SEK, to the VICI-Disease consortium, of which 53% is direct contribution for ExpreS2ion’s part of the project costs. The aim is to obtain clinical proof-of-concept of a Nipah virus (NiV) vaccine candidate within four years.CEO Bent Frandsen comments: “This is an important project in an area of public health concern that will benefit from our advantageous

Rejlers signs framework agreement with the Swedish Transport Administration on skills supply in infrastructure

Rejlers has signed a significant framework agreement with the Swedish Transport Administration regarding the agency's strategic skills supply work. The agreement covers assistant positions, urban planners, traffic engineers, planners and investigators and extends over a period of two years with the possibility of extension for a further two years.Through the framework agreement, Rejlers will play a key role in recruiting and providing newly graduated engineers and planners to strengthen the Swedish Transport Administration's organisation. This includes entry-level positions such as urban

Invitation to presentation of Sectra’s six-month interim report 2023/2024

Linköping, Sweden – December 1, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) invites investors, analysts, and the media to a presentation of the company’s six-month report with President Torbjörn Kronander and CFO Jessica Holmquist.Publication of the financial report: 8:15 a.m. (CET) on December 15, 2023Report presentation: 10:00 a.m. (CET) on the same date To participate, follow the instructions on Sectra’s website investor.sectra.com/q2report2324 .

Change in Aiforia Technologies Plc’s Management Team

Aiforia Technologies Plc, Company Release, December 1, 2023 09:00 a.m. EET. Aiforia Technologies Plc reinforces its Management Team to strengthen the implementation of the company’s growth strategy.Panu Kauppila has been appointed Chief Product Officer and a member of the Management Team (previously Vice President of Product Management) as of 1.12.2023. He has been with the company since June 2022. Panu has played a key role in defining Aiforia's product portfolio and prioritizing product development. In particular, he has led the definition, development, and delivery of clinical product

Discontinuation of two CRYSTALIZE evidence trials

1 December 2023 Update on CRYSTALIZE evidence trials Discontinuation of STABILIZE-CKD and DIALIZE-Outcomes Phase III trials AstraZeneca has decided to discontinue the STABILIZE-CKD and DIALIZE-Outcomes Phase III evidence trials for Lokelma (sodium zirconium cyclosilicate). The decision was made due to substantially increased enrolment timelines and low event rates, respectively, which made it prohibitive to deliver study results within a timeframe to meaningfully advance clinical practice. STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme,

Arctic Bioscience – More than 75% recruited in the phase IIb HeROPA clinical trial

With reference to the Q3 update from November 2[nd] 2023 which reported more than 50% recruited patients to the phase IIb clinical trial HeROPA, Arctic Bioscience is pleased to report that we have now recruited more than 75% of the patients required for the trial.The HeROPA phase IIb clinical trial of HRO350 - a novel, oral drug candidate for the treatment of mild-to-moderate psoriasis - is ongoing in 5 countries in Europe; UK, Germany, Poland, Finland and Norway. As planned, recruitment speed has increased throughout fall as new clinics have been activated. Recruitment is going

There are no items matching the current filter
There are no more items matching the current filter
Back to top